PHR
Phreesia, Inc.
NYSE · Healthcare · Medical - Healthcare Information Services · US
$10.82
−2.52%Sep 2, 2026, 22:11 UTC
Phreesia reported Q2 fiscal 2026 earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.11 per share, compared to $0.01 per share a year ago.
Sep 2, 2026, 20:14 UTC
Phreesia, Inc. reported Q2 FY2027 revenue of $129.5 million, up 10% year-over-year, with net income of $1.9 million and diluted EPS of $0.03.
Source:Jul 23, 2026, 10:51 UTC
Phreesia and March of Dimes announced a partnership to enhance physician-patient conversations during prenatal and postpartum appointments.
Source:Jul 11, 2026, 14:45 UTC
A federal securities class action lawsuit has been filed against Phreesia, Inc. and its executives, alleging violations of federal securities laws by making false or misleading statements about the company's growth potential and demand in its Network Solutions segment.
Source:Jul 5, 2026, 16:00 UTC
A class action lawsuit was filed against Phreesia, Inc. and certain officers alleging violations of federal securities laws.
Jul 1, 2026, 13:34 UTC
Bernstein Liebhard LLP announces an investigation of Phreesia, Inc. regarding potential securities law violations.
Source:Jun 3, 2026, 05:56 UTC
Phreesia, Inc. is sued in a class action lawsuit for securities law violations.
May 30, 2026, 13:53 UTC
A securities class action lawsuit has been filed against Phreesia, Inc. on behalf of purchasers of its common stock between May 8, 2025 and March 30, 2026.
Source: